Log in to save to my catalogue

Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment

Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3100275066

Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment

About this item

Full title

Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment

Publisher

Cham: Springer International Publishing

Journal title

Daru, 2024-12, Vol.32 (2), p.649-664

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Glatiramer acetate (GA), a commonly used treatment for multiple sclerosis (MS), requires long-term frequent injections to ensure its effectiveness. This often leads to adverse effects, patient noncompliance, and economic inefficiency.
Objectives
In this study, poloxamer, as a thermosensitive polymer modified by chitosan (CS) and...

Alternative Titles

Full title

Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3100275066

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3100275066

Other Identifiers

ISSN

2008-2231,1560-8115

E-ISSN

2008-2231

DOI

10.1007/s40199-024-00532-z

How to access this item